J. M. Mendoza

[Consensus statement of the Spanish Society of Rheumatology on risk management of biologic therapy in rheumatic patients].

L. Carmona, I. González-Álvaro, J. Andreu, 2011, Reumatología Clínica.

Sialodochitis fibrinosa (kussmaul disease) report of 3 cases and literature review

M. J. Palop, J. Sanz, J. M. Mendoza, 2016, Medicine.

Consensus Statement of the Spanish Society of Rheumatology on the management of biologic therapies in Spondyloarthritis except for Psoriatic Arthritis

S. Muñoz Fernández, C. Fernández Carballido, J. Mulero Mendoza, 2011 .

Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practising rheumatologists.

M. Dougados, I. Olivieri, J. Avouac, 2008, Rheumatology.

Correction to: Influence of HLA-B27 on the Ankylosing Spondylitis phenotype: results from the REGISPONSER database

M. M. Moreno Ramos, E. C. Estevez, J. Sueiro, 2020, Arthritis Research & Therapy.

Initial Treatment in Septic Arthritis: Medical Versus Surgical Approach

M. J. Palop, J. Sanz, J. M. Mendoza, 2017 .

Consensus Statement of the Spanish Society of Rheumatology on Risk Management of Biologic Therapy in Rheumatic Patients

E. Mola, E. Loza, R. Queiró, 2011 .